Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Amano

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Toxicological Sciences|April 1, 2026
Considerations for infection risks identified in target safety reviewYuichiro Amano, Yoshitaka Inui, Satoko Yoshioka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 4, 2015
[Case Report: Clindamycin with Primaquine Therapy for Severe Pneumocystis Pneumonia]Yukihiro Yoshimura, Youhei Sakamoto, Yuichiro Amano, et al.
The Journal of Toxicological Sciences|November 3, 2025
Incorporation of target safety review in drug discoveryYuichiro Amano, Brandon Jeffy, Hisashi Anayama, et al.
European Journal of Pharmacology|December 24, 2013
Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primatesYuichiro Amano, Mitsuyuki Shimada, Shotaro Miura, et al.
Biochemical and Biophysical Research Communications|March 22, 2017
Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse modelYo Muraki, Yukimasa Makita, Midori Yamasaki, et al.
Journal of Travel Medicine|July 15, 2015
Round Pneumonia With Murine Typhus After Travel to IndonesiaYukihiro Yoshimura, Yohei Sakamoto, Lee Kwangyeol, et al.
Life Sciences|May 3, 2014
Antidyslipidemic effects of a farnesoid X receptor antagonist in primatesYuichiro Amano, Mitsuyuki Shimada, Shotaro Miura, et al.
Pharmacological Reports : PR|January 26, 2018
Farnesoid X receptor antagonist exacerbates dyslipidemia in miceYuichiro Amano, Hiroko Yamakawa, Kazuko Yonemori, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2016
Penicillium marneffei Infection with β-D-glucan Elevation: A Case Report and Literature ReviewYukihiro Yoshimura, Yohei Sakamoto, Kwangyeol Lee, et al.
Biochemical Pharmacology|November 12, 2003
Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytesTomoyuki Nishimoto, Ryuichi Tozawa, Yuichiro Amano, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Toxicological Sciences|April 1, 2026
Considerations for infection risks identified in target safety reviewYuichiro Amano, Yoshitaka Inui, Satoko Yoshioka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 4, 2015
[Case Report: Clindamycin with Primaquine Therapy for Severe Pneumocystis Pneumonia]Yukihiro Yoshimura, Youhei Sakamoto, Yuichiro Amano, et al.
The Journal of Toxicological Sciences|November 3, 2025
Incorporation of target safety review in drug discoveryYuichiro Amano, Brandon Jeffy, Hisashi Anayama, et al.
European Journal of Pharmacology|December 24, 2013
Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primatesYuichiro Amano, Mitsuyuki Shimada, Shotaro Miura, et al.
Biochemical and Biophysical Research Communications|March 22, 2017
Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse modelYo Muraki, Yukimasa Makita, Midori Yamasaki, et al.
Journal of Travel Medicine|July 15, 2015
Round Pneumonia With Murine Typhus After Travel to IndonesiaYukihiro Yoshimura, Yohei Sakamoto, Lee Kwangyeol, et al.
Life Sciences|May 3, 2014
Antidyslipidemic effects of a farnesoid X receptor antagonist in primatesYuichiro Amano, Mitsuyuki Shimada, Shotaro Miura, et al.
Pharmacological Reports : PR|January 26, 2018
Farnesoid X receptor antagonist exacerbates dyslipidemia in miceYuichiro Amano, Hiroko Yamakawa, Kazuko Yonemori, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2016
Penicillium marneffei Infection with β-D-glucan Elevation: A Case Report and Literature ReviewYukihiro Yoshimura, Yohei Sakamoto, Kwangyeol Lee, et al.
Biochemical Pharmacology|November 12, 2003
Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytesTomoyuki Nishimoto, Ryuichi Tozawa, Yuichiro Amano, et al.
Pageof 3